Advertisement
RayBiotech
RayBiotech

Most Recent

image: Doubled Gene Boosted Brain Power

Doubled Gene Boosted Brain Power

By | May 7, 2012

Human-specific duplications of a gene involved in brain development may have contributed to our species’ unique intelligence.

6 Comments

image: Stem Cell Suicide Switch

Stem Cell Suicide Switch

By | May 3, 2012

Human embryonic stem cells swiftly kill themselves in response to DNA damage.

10 Comments

image: The Sugar Lnc

The Sugar Lnc

By | May 1, 2012

Genes that react to cellular sugar content are regulated by a long non-coding RNA via an unexpected mechanism

2 Comments

image: Boyle’s Monsters, 1665

Boyle’s Monsters, 1665

By | May 1, 2012

From accounts of deformed animals to scratch-and-sniff technology, Robert Boyle's early contributions to the Royal Society of London were prolific and wide ranging.

0 Comments

image: Freezing Time

Freezing Time

By | May 1, 2012

Targeting the briefest moment in chemistry may lead to an exceptionally strong new class of drugs.

15 Comments

image: New Target for Aspirin

New Target for Aspirin

By | April 20, 2012

New work on salicylate, a natural component of aspirin, suggests that activation of the energy-sensing AMP kinase may underlie some of aspirin’s health benefits.

6 Comments

image: An Antidote for Cocaine Overdose?

An Antidote for Cocaine Overdose?

By | April 19, 2012

A novel antibody with a powerful affinity for cocaine shows promise in reversing the deadly effects of an overdose.

2 Comments

image: Repurpose Failed Drugs, NIH Urges

Repurpose Failed Drugs, NIH Urges

By | April 16, 2012

Francis Collins says pharmaceutical companies should help bridge the gap between basic science and applications with old drug compounds.

0 Comments

image: Size Matters to Industry

Size Matters to Industry

By | April 11, 2012

Large molecules are more likely to make it to market these days than small molecules, according to new reports.

0 Comments

image: Obesity Drugs in Check

Obesity Drugs in Check

By | April 2, 2012

The FDA may require weight-loss drugs to undergo clinical trials to see if they pose a risk of heart attack.

2 Comments

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement
LI-COR
LI-COR

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Biology Research
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
Advertisement
The Scientist
The Scientist